Individualised immunosuppression improves prognosis for liver transplant patients

A biopsy needle with which doctors regularly take tissue samples in order to individually control the immunosuppression for each patient. Copyright: 'Karin Kaiser / MHH. Regular biopsies lead to less immunosuppression and fewer side effects Stand: 01. After a liver transplant, patients have to take immune-suppressing drugs for the rest of their lives. These so-called immunosuppressants prevent the organ from being rejected. However, the drugs increase the risk of cancer and serious infections. They can also significantly impair kidney function and even lead to dialysis.